|
|
Effect of Bushen Kangshuai Tablets combined with traditional western medicine in the treatment of type 2 diabetic nephropathy of kidney deficiency and phlegm stagnation in elderly patients |
HUANG Guo-wei |
Department of Nephrology,Kaizhou District People′s Hospital of Chongqing City,Chongqing 405400,China |
|
|
Abstract Objective To explore the clinical effect of Bushen Kangshuai Tablets combined with conventional western medicine in the treatment of type 2 diabetic nephropathy of kidney deficiency and phlegm stagnation in elderly patients.Methods 194 patients with type 2 diabetic nephropathy of kidney deficiency and phlegm stagnation who were treated in our hospital from April 2013 to April 2016 were selected and divided into observation group (n=97)and control group (n=97)according to the odd number and even number of the admission number.Patients in the control group were only given conventional western medicine,while patients in the observation group were treated with Bushen Kangshuai Tablets on the basis of the control group.Biochemical indicators and improvement of symptoms of traditional Chinese medicine before and after treatment were compared between two groups.Results After 16 weeks of treatment, the biochemical indicators and TCM syndrome scores of two groups was significantly lower than that before treatment (P<0.05);lymphocyte group CD4+/CD8+,urinary ACR,urinary Alb,FBG,2 h PBG,HbA1c in the observation group were all better than those in the control group,and the difference was statistically significant(P<0.05);improvement of scores of shortness of breath and laziness to speak,limb numbness,frequent urination,low back pain,abdominal fullness and distention in the observation group was better than that in the control group respectively,and there was statistical difference (P<0.05).Conclusion Bushen Kangshuai Tablets combined with conventional western medicine in the treatment of type 2 diabetic nephropathy of kidney deficiency and phlegm stagnation in elderly patients is safe and effective.It can effectively maintain the blood sugar level,regulate the immunity of the body and improve the physical syndromes of TCM,which can be promoted and applied in clinical treatment.
|
|
|
|
|
[1] |
杨静.老年2型糖尿病慢性并发症发病时间及临床危险因素研究[J].中国现代医生,2016,54(14):41-43.
|
[2] |
罗检成.中医活血化瘀法治疗2型糖尿病高脂血症的临床效果[J].中医临床研究,2015,7(2):56-57.
|
[3] |
仝小林,周强,赵林华,等.糖尿病肾病的中医辨治经验[J].中华中医药杂志,2014,29(1):144-146.
|
[4] |
李敏州,高彦彬,马鸣飞,等.糖尿病肾病发病机制研究进展[J].中国实验方剂学杂志,2012,18(22):344-348.
|
[5] |
谢日升,梁彩云,曾光,等.β2-微球蛋白、尿微量白蛋白/肌酐比值对诊断早期糖尿病肾病的价值[J].山西中医学院学报,2016,17(4):63-65.
|
[6] |
周静,高晟,吴深涛.补肾抗衰片对肾虚痰瘀型2型糖尿病临床疗效及中医证候的影响[J].天津药学,2015,27(4):37-39.
|
[7] |
中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,22(11):792-801.
|
[8] |
梁茂新,高天舒.《中药新药临床研究指导原则》脏腑诸证考察与分析[J].中国中医基础医学杂志,2008,14(5):330-331.
|
[9] |
刘玉宁,尕丽娅,马雷雷.糖尿病肾病的中医命名与病因病机[J].中华肾病研究电子杂志,2013,2(4):201-203.
|
[10] |
吴彦,邬金玲.中医药治疗糖尿病脂代谢紊乱研究进展[J].黑龙江中医药,2014,43(4):75-77.
|
[11] |
张金锋,石梅,邢建华,等.糖尿病肾病血清白蛋白、尿酸与肾小球滤过率的相关性评价[J].中国临床医生,2014,42(9):41-43.
|
[12] |
周静,高晟,吴深涛.补肾抗衰片对肾虚痰瘀型2型糖尿病高脂血症患者的影响[J].天津中医药,2015,32(8):473-476.
|
[13] |
张光银,李明,许颖智,等.补肾抗衰片干预动脉粥样硬化的氧化应激机制研究[J].世界科学技术-中医药现代化,2014,16(5):1097-1102.
|
[14] |
张光银,李明,许颖智,等.动脉粥样硬化家兔蛋白质硝基化修饰及补肾抗衰片干预研究[J].中国实验方剂学杂志,2014,20(9):179-184.
|
[15] |
崔国利,李升.糖尿病肾病患者血清FGF-2、TGF-β及CD4+T细胞的数量变化[J].细胞与分子免疫学杂志,2014,30(2):197-199.
|
|
|
|